Trials / Sponsors / Antios Therapeutics, Inc
Antios Therapeutics, Inc
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Chronic Hepatitis b | Phase 2 | 2022-04-11 |
| Terminated | Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects Chronic Hepatitis b | Phase 1 | 2022-03-29 |
| Completed | A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects Drug Drug Interaction | Phase 1 | 2021-10-28 |
| Completed | A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects Drug Interaction | Phase 1 | 2021-10-27 |
| Terminated | A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Hepatitis B, Chronic, Hepatitis D | Phase 2 | 2021-03-30 |
| Completed | A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 Hepatitis B, Chronic | Phase 1 | 2020-02-05 |